-
1
-
-
0347133334
-
Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes
-
Saydah SH, Cowie FJ. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA. 2004; 291:335-342.
-
(2004)
JAMA
, vol.291
, pp. 335-342
-
-
Saydah, S.H.1
Cowie, F.J.2
-
2
-
-
0037092995
-
Diabetes and atherosclerosis: Epidemiology, pathophysiology, and management
-
Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA. 2002;287:2570-2581.
-
(2002)
JAMA
, vol.287
, pp. 2570-2581
-
-
Beckman, J.A.1
Creager, M.A.2
Libby, P.3
-
3
-
-
0032815936
-
In-hospital outcome for diabetic patients with acute myocardial infarction in the thrombolytic era
-
Kaergaard SC, Hansen HH, Fog L, et al. In-hospital outcome for diabetic patients with acute myocardial infarction in the thrombolytic era. Scand Cardiovasc J. 1999;33:166-170.
-
(1999)
Scand Cardiovasc J.
, vol.33
, pp. 166-170
-
-
Kaergaard, S.C.1
Hansen, H.H.2
Fog, L.3
-
4
-
-
0034730110
-
Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction: Results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) registry
-
Malmberg K, Yusuf S, Gerstein HC, et al. Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction: results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) registry. Circulation. 2000;102: 1014-1019.
-
(2000)
Circulation
, vol.102
, pp. 1014-1019
-
-
Malmberg, K.1
Yusuf, S.2
Gerstein, H.C.3
-
5
-
-
0033867999
-
Diabetes mellitus in cardiogenic shock complicating acute myocardial infarction: A report from the SHOCK trial registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK?
-
Shindler DM, Palmeri ST, Antonelli TA, et al. Diabetes mellitus in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK trial registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK? J Am Coll Cardiol. 2000; 36:1097-1103.
-
(2000)
J Am Coll Cardiol.
, vol.36
, pp. 1097-1103
-
-
Shindler, D.M.1
Palmeri, S.T.2
Antonelli, T.A.3
-
6
-
-
0037903801
-
Impact of diabetes on mortality after the first myocardial infarction
-
The FINMONICA Myocardial Infarction Register Study Group
-
Miettinen H, Lehto S, Salomaa V, et al. Impact of diabetes on mortality after the first myocardial infarction. The FINMONICA Myocardial Infarction Register Study Group. Diabetes Care. 1998;21:69-75.
-
(1998)
Diabetes Care
, vol.21
, pp. 69-75
-
-
Miettinen, H.1
Lehto, S.2
Salomaa, V.3
-
7
-
-
25444458274
-
Are even impaired fasting blood glucose levels postoperatively associated with mortality after CABG surgery?
-
Anderson RE, Klerdal K, Ivert T, et al. Are even impaired fasting blood glucose levels postoperatively associated with mortality after CABG surgery? Eur Heart J. 2005;26:1513-1518.
-
(2005)
Eur Heart J.
, vol.26
, pp. 1513-1518
-
-
Anderson, R.E.1
Klerdal, K.2
Ivert, T.3
-
8
-
-
0037454139
-
Acute, short-term hyperglycemia enhances shear stress-induced platelet activation in patients with type II diabetes mellitus
-
Gresele P, Guglielmini G, De Angelis M, et al. Acute, short-term hyperglycemia enhances shear stress-induced platelet activation in patients with type II diabetes mellitus. J Am Coll Cardiol. 2003;41:1013-1020.
-
(2003)
J Am Coll Cardiol.
, vol.41
, pp. 1013-1020
-
-
Gresele, P.1
Guglielmini, G.2
De Angelis, M.3
-
9
-
-
10744223992
-
Effects of stress hyperglycemia on acute myocardial infarction: Role of inflammatory immune process in functional cardiac outcome
-
Marfella R, Siniscalchi M, Esposito K, et al. Effects of stress hyperglycemia on acute myocardial infarction: role of inflammatory immune process in functional cardiac outcome. Diabetes Care. 2003;3:3129-3135.
-
(2003)
Diabetes Care
, vol.3
, pp. 3129-3135
-
-
Marfella, R.1
Siniscalchi, M.2
Esposito, K.3
-
10
-
-
0037145914
-
Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era?
-
Wahab NN, Cowden EA, Pearce NJ, et al. Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era? J Am Coll Cardiol. 2002; 40:1748-1754.
-
(2002)
J Am Coll Cardiol.
, vol.40
, pp. 1748-1754
-
-
Wahab, N.N.1
Cowden, E.A.2
Pearce, N.J.3
-
11
-
-
15944403234
-
Hyperglycemia is an important predictor of impaired coronary flow before reperfusion therapy in ST-segment elevation myocardial infarction
-
Timmer JR, Ottervanger JP, de Boer MJ, et al. Hyperglycemia is an important predictor of impaired coronary flow before reperfusion therapy in ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2005;45:999-1002.
-
(2005)
J Am Coll Cardiol.
, vol.45
, pp. 999-1002
-
-
Timmer, J.R.1
Ottervanger, J.P.2
de Boer, M.J.3
-
12
-
-
0030007349
-
Potential mechanisms promoting restenosis in diabetic patients
-
Aronson D, Bloomgarden Z, Rayfield EJ. Potential mechanisms promoting restenosis in diabetic patients. J Am Coll Cardiol. 1996;27:528-535.
-
(1996)
J Am Coll Cardiol.
, vol.27
, pp. 528-535
-
-
Aronson, D.1
Bloomgarden, Z.2
Rayfield, E.J.3
-
13
-
-
0347228970
-
Optimal glycemic control is associated with a lower rate of target vessel revascularization in treated type II diabetic patients undergoing elective percutaneous intervention
-
Corpus RA, George PB, House JA, et al, Optimal glycemic control is associated with a lower rate of target vessel revascularization in treated type II diabetic patients undergoing elective percutaneous intervention. J Am Coll Cardiol. 2004;43:8-14.
-
(2004)
J Am Coll Cardiol.
, vol.43
, pp. 8-14
-
-
Corpus, R.A.1
George, P.B.2
House, J.A.3
-
14
-
-
0041488807
-
Effect of fasting glucose levels on mortality rate in patients with and without diabetes mellitus and coronary artery disease undergoing percutaneous coronary intervention
-
Muhlestein JB, Anderson JL, Home BD, et al. Effect of fasting glucose levels on mortality rate in patients with and without diabetes mellitus and coronary artery disease undergoing percutaneous coronary intervention. Am Heart J. 2003;146:351-358.
-
(2003)
Am Heart J.
, vol.146
, pp. 351-358
-
-
Muhlestein, J.B.1
Anderson, J.L.2
Home, B.D.3
-
15
-
-
13544269380
-
Impact of diabetes mellitus on myocardial perfusion after primary angioplasty in patients with acute myocardial infarction
-
Prasad A, Stone GW, Stuckey TD, et al. Impact of diabetes mellitus on myocardial perfusion after primary angioplasty in patients with acute myocardial infarction. J Am Coll Cardiol. 2005;45:508-514.
-
(2005)
J Am Coll Cardiol.
, vol.45
, pp. 508-514
-
-
Prasad, A.1
Stone, G.W.2
Stuckey, T.D.3
-
16
-
-
0001903932
-
Abciximab associated with primary angioplasty in acute myocardial infarction: The ADMIRAL study, 30 day final results
-
Montalescot G, Barragan P, Wittenberg O, et al. Abciximab associated with primary angioplasty in acute myocardial infarction: the ADMIRAL study, 30 day final results. Circulation. 1999; 100(suppl):1-87.
-
(1999)
Circulation
, vol.100
, Issue.SUPPL.
, pp. 1-87
-
-
Montalescot, G.1
Barragan, P.2
Wittenberg, O.3
-
17
-
-
0141765874
-
Benefits and risks of abciximab use in primary angioplasty for acute myocardial infarction
-
The Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial
-
Tcheng JE, Kandzari DE, Grines CL, et al. Benefits and risks of abciximab use in primary angioplasty for acute myocardial infarction. The Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial. Circulation. 2003;108:1316-1323.
-
(2003)
Circulation
, vol.108
, pp. 1316-1323
-
-
Tcheng, J.E.1
Kandzari, D.E.2
Grines, C.L.3
-
18
-
-
0033230771
-
Effect of glycoprotein IIb/IIIa receptor blockade on platelet-leukocyte interaction and surface expression of leukocyte integrin Mac-1 in acute myocardial infarction
-
Neumann FJ, Zolnhofer D, Fakhoury L, et al. Effect of glycoprotein IIb/ IIIa receptor blockade on platelet-leukocyte interaction and surface expression of leukocyte integrin Mac-1 in acute myocardial infarction. J Am Coll Cardiol. 1999:34:1420-1426.
-
(1999)
J Am Coll Cardiol.
, vol.34
, pp. 1420-1426
-
-
Neumann, F.J.1
Zolnhofer, D.2
Fakhoury, L.3
-
19
-
-
12844280006
-
Relation between electrocardiographic ST-segment resolution and early and late outcomes after primary percutaneous coronary intervention for acute myocardial infarction
-
Brodie BR, Stuckey TD, Hansen C. Relation between electrocardiographic ST-segment resolution and early and late outcomes after primary percutaneous coronary intervention for acute myocardial infarction. Am J Cardiol. 2005;95: 343-8.
-
(2005)
Am J Cardiol.
, vol.95
, pp. 343-348
-
-
Brodie, B.R.1
Stuckey, T.D.2
Hansen, C.3
-
20
-
-
0035808028
-
Platelet glycoprotein IIb/IIIa inhibitors reduce mortality in diabetic patients with non-ST-segment elevation acute coronary syndromes
-
Roffi M, Chew DP, Mukherjee D, et al. Platelet glycoprotein IIb/IIIa inhibitors reduce mortality in diabetic patients with non-ST-segment elevation acute coronary syndromes. Circulation. 2001;104:2767-2771.
-
(2001)
Circulation
, vol.104
, pp. 2767-2771
-
-
Roffi, M.1
Chew, D.P.2
Mukherjee, D.3
-
21
-
-
0033613541
-
Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus: Results of the EPISTENT (Evaluation of Platelet IIb /IIIa Inhibitor for Stenting Trial) diabetic substudy
-
Marso SP, Lincoff AM, Ellis SG, et al. Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus: results of the EPISTENT (Evaluation of Platelet IIb/IIIa Inhibitor for Stenting Trial) diabetic substudy. Circulation. 1999;100:2477-2484.
-
(1999)
Circulation
, vol.100
, pp. 2477-2484
-
-
Marso, S.P.1
Lincoff, A.M.2
Ellis, S.G.3
-
22
-
-
0034654627
-
Abciximab reduces mortality in diabetics following percutaneous coronary intervention
-
Bhatt DL, Marso SP, Lincoff AM, et al. Abciximab reduces mortality in diabetics following percutaneous coronary intervention. J Am Coll Cardiol. 2000;35:922-928.
-
(2000)
J Am Coll Cardiol.
, vol.35
, pp. 922-928
-
-
Bhatt, D.L.1
Marso, S.P.2
Lincoff, A.M.3
-
23
-
-
0037062662
-
Impact of different platelet glycoprotein IIb/IIIa receptor inhibitors among diabetic patients undergoing percutaneous coronary intervention: Do Tirofiban And ReoPro Give similar Efficacy outcomes Trial (TARGET) 1-year follow-up
-
Roffi M, Moliterno DJ, Meier B, et al. Impact of different platelet glycoprotein IIb/IIIa receptor inhibitors among diabetic patients undergoing percutaneous coronary intervention: do Tirofiban And ReoPro Give similar Efficacy outcomes Trial (TARGET) 1-year follow-up. Circulation. 2002;105:2730-2736.
-
(2002)
Circulation
, vol.105
, pp. 2730-2736
-
-
Roffi, M.1
Moliterno, D.J.2
Meier, B.3
-
24
-
-
0029972376
-
Coronary angioplasty in diabetic patients
-
The National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry
-
Kip KE, Faxon DP, Detre KM, et al. Coronary angioplasty in diabetic patients. The National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. Circulation. 1996;94:1818-1825.
-
(1996)
Circulation
, vol.94
, pp. 1818-1825
-
-
Kip, K.E.1
Faxon, D.P.2
Detre, K.M.3
-
25
-
-
0028918473
-
Influence of diabetes mellitus on early and late outcome after percutaneous transluminal coronary angioplasty
-
Stein B, Weintraub WS, Gebhart SP, et al. Influence of diabetes mellitus on early and late outcome after percutaneous transluminal coronary angioplasty. Circulation. 1995;91:979-989.
-
(1995)
Circulation
, vol.91
, pp. 979-989
-
-
Stein, B.1
Weintraub, W.S.2
Gebhart, S.P.3
-
26
-
-
10744221624
-
Volumetric analysis of in-stent hyperplasia in diabetic patients treated with or without abciximab
-
Chaves AJ, Sousa AG, Mottos LA, et al. Volumetric analysis of in-stent hyperplasia in diabetic patients treated with or without abciximab. Circulation. 2004;109:861-866.
-
(2004)
Circulation
, vol.109
, pp. 861-866
-
-
Chaves, A.J.1
Sousa, A.G.2
Mottos, L.A.3
-
27
-
-
20844448202
-
Randomized clinical trial of abciximab in diabetic patients undergoing elective percutaneous coronary interventions after treatment with a high loading dose of clopidogrel
-
Mehilli J, Kastrati A, Schuhlen H, et al. Randomized clinical trial of abciximab in diabetic patients undergoing elective percutaneous coronary interventions after treatment with a high loading dose of clopidogrel. Circulation. 2004;110:3627-3635.
-
(2004)
Circulation
, vol.110
, pp. 3627-3635
-
-
Mehilli, J.1
Kastrati, A.2
Schuhlen, H.3
-
28
-
-
0343036110
-
Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease
-
The Bypass Angioplasty Revascularization Investigation (BARI)
-
Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease. The Bypass Angioplasty Revascularization Investigation (BARI). Circulation. 1997;96: 1761-1769.
-
(1997)
Circulation
, vol.96
, pp. 1761-1769
-
-
-
29
-
-
0030876311
-
Restenosis rates in diabetic patients: A comparison of coronary stenting and balloon angioplasty in native coronary vessels
-
Van Belle E, Bauters C, Hubert E, et al. Restenosis rates in diabetic patients: a comparison of coronary stenting and balloon angioplasty in native coronary vessels. Circulation. 1997;96: 1454-1460.
-
(1997)
Circulation
, vol.96
, pp. 1454-1460
-
-
Van Belle, E.1
Bauters, C.2
Hubert, E.3
-
30
-
-
0035979350
-
Clinical and economic impact of diabetes mellitus on percutaneous and surgical treatment of multivessel coronary disease patients: Insights from the Arterial Revascularization Therapy Study (ARTS) trial
-
Abizaid A, Costa MA, Centemero M, et al. Clinical and economic impact of diabetes mellitus on percutaneous and surgical treatment of multivessel coronary disease patients: insights from the Arterial Revascularization Therapy Study (ARTS) trial. Circulation. 2001;104:533-538.
-
(2001)
Circulation
, vol.104
, pp. 533-538
-
-
Abizaid, A.1
Costa, M.A.2
Centemero, M.3
-
31
-
-
0037036830
-
Diabetes mellitus increases short-term mortality and morbidity in patients undergoing coronary artery bypass surgery
-
Carson JL, Scholz PM, Chen AY, et al. Diabetes mellitus increases short-term mortality and morbidity in patients undergoing coronary artery bypass surgery. J Am Coll Cardiol. 2002;40:418-423.
-
(2002)
J Am Coll Cardiol.
, vol.40
, pp. 418-423
-
-
Carson, J.L.1
Scholz, P.M.2
Chen, A.Y.3
-
32
-
-
0030768839
-
Problem of angioplasty in diabetics
-
Ellis SG, Narins CR. Problem of angioplasty in diabetics. Circulation. 1997;90:1707-1710.
-
(1997)
Circulation
, vol.90
, pp. 1707-1710
-
-
Ellis, S.G.1
Narins, C.R.2
-
33
-
-
20244382131
-
Outcomes with polymer-based paclitaxel eluting stent in patients with diabetes mellitus
-
Hermiller JB, Raziner A, Cannon L, et al. Outcomes with polymer-based paclitaxel eluting stent in patients with diabetes mellitus. J Am Coll Cardiol. 2005;45:1172-1179.
-
(2005)
J Am Coll Cardiol.
, vol.45
, pp. 1172-1179
-
-
Hermiller, J.B.1
Raziner, A.2
Cannon, L.3
-
34
-
-
10744222911
-
Analysis of 1-year clinical outcomes in the SIRIUS trial
-
Holmes DR, Leon MB, Moses JW, et al. Analysis of 1-year clinical outcomes in the SIRIUS trial. Circulation. 2004;109:634-640.
-
(2004)
Circulation
, vol.109
, pp. 634-640
-
-
Holmes, D.R.1
Leon, M.B.2
Moses, J.W.3
-
35
-
-
23844538250
-
Paclitaxel-eluting or sirolimus eluting stents to prevent restenosis in diabetic patients
-
Dibra A, Kastrati A, Mehilli J, et al. Paclitaxel-eluting or sirolimus eluting stents to prevent restenosis in diabetic patients. N Engl J Med. 2005;353:663-670.
-
(2005)
N Engl J Med.
, vol.353
, pp. 663-670
-
-
Dibra, A.1
Kastrati, A.2
Mehilli, J.3
-
36
-
-
0033598089
-
Prevalence and correlates of elevated serum creatinine levels
-
Culleton BF, Larson MG, Evans JC, et al. Prevalence and correlates of elevated serum creatinine levels. Arch Intern Med. 1999;159:1785-1790.
-
(1999)
Arch Intern Med.
, vol.159
, pp. 1785-1790
-
-
Culleton, B.F.1
Larson, M.G.2
Evans, J.C.3
-
37
-
-
0036176161
-
K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification
-
National Kidney Foundation
-
National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39:S1-S266.
-
(2002)
Am J Kidney Dis.
, vol.39
-
-
-
38
-
-
1642502319
-
National Kidney Foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification
-
Levey AS, Coresh J, Balk E, et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med. 2003;39:137-147.
-
(2003)
Ann Intern Med.
, vol.39
, pp. 137-147
-
-
Levey, A.S.1
Coresh, J.2
Balk, E.3
-
39
-
-
4143068072
-
Cardiovascular disease and chronic kidney disease: Insights and an update
-
Best PJ, Reddan DN, Berger PB, et al. Cardiovascular disease and chronic kidney disease: insights and an update. Am Heart J. 2004;148:230-242.
-
(2004)
Am Heart J.
, vol.148
, pp. 230-242
-
-
Best, P.J.1
Reddan, D.N.2
Berger, P.B.3
-
40
-
-
1942506539
-
Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: A pooled analysis of community-based studies
-
Weiner D, Tighiouart H, Amin M, et al. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol. 2004;15:1307-1315.
-
(2004)
J Am Soc Nephrol.
, vol.15
, pp. 1307-1315
-
-
Weiner, D.1
Tighiouart, H.2
Amin, M.3
-
41
-
-
28644449703
-
Piecing together the evidence on anemia: The link between chronic kidney disease and cardiovascular disease
-
McCullough PA, Lepor NE. Piecing together the evidence on anemia: the link between chronic kidney disease and cardiovascular disease. Rev Cardiovasc Med. 2005;6(suppl 3):S4-S12.
-
(2005)
Rev Cardiovasc Med.
, vol.6
, Issue.SUPPL. 3
-
-
McCullough, P.A.1
Lepor, N.E.2
-
42
-
-
0042328325
-
Creatinine clearance and adverse hospital outcomes in patients with acute coronary syndromes: Findings from the Global Registry of Acute Coronary Events (GRACE)
-
Santopinto JJ, Fox KA, Goldberg RJ, et al. Creatinine clearance and adverse hospital outcomes in patients with acute coronary syndromes: findings from the Global Registry of Acute Coronary Events (GRACE). Heart. 2003;89: 1003-1008.
-
(2003)
Heart
, vol.89
, pp. 1003-1008
-
-
Santopinto, J.J.1
Fox, K.A.2
Goldberg, R.J.3
-
43
-
-
27144546821
-
Renal function, concomitant medication use and outcomes following acute coronary syndromes
-
Reddan DN, Szczech L, Bhapkar MV, et al. Renal function, concomitant medication use and outcomes following acute coronary syndromes. Nephrol Dial Transplant. 2005;20:2105-2112.
-
(2005)
Nephrol Dial Transplant
, vol.20
, pp. 2105-2112
-
-
Reddan, D.N.1
Szczech, L.2
Bhapkar, M.V.3
-
44
-
-
0036788828
-
Acute myocardial infarction and renal dysfunction: A high-risk combination
-
Wright RS, Reeder GS, Herzog CA, et al. Acute myocardial infarction and renal dysfunction: a high-risk combination. Ann Intern Med. 2002; 137:563-570.
-
(2002)
Ann Intern Med.
, vol.137
, pp. 563-570
-
-
Wright, R.S.1
Reeder, G.S.2
Herzog, C.A.3
-
45
-
-
0037012408
-
The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions
-
Best PJ, Lennon R, Ting HH, et al. The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol. 2002;39:1113-1119.
-
(2002)
J Am Coll Cardiol.
, vol.39
, pp. 1113-1119
-
-
Best, P.J.1
Lennon, R.2
Ting, H.H.3
-
46
-
-
0033028112
-
Renal failure predisposes to adverse outcome after coronary artery bypass surgery
-
VA Cooperative Study #5
-
Anderson RJ, O'Brien M, MaWhinney S, et al. Renal failure predisposes to adverse outcome after coronary artery bypass surgery. VA Cooperative Study #5. Kidney Int. 1999;55:1057-1062.
-
(1999)
Kidney Int.
, vol.55
, pp. 1057-1062
-
-
Anderson, R.J.1
O'Brien, M.2
MaWhinney, S.3
-
47
-
-
0037076406
-
Outcomes of patients with chronic renal insufficiency in the Bypass Angioplasty Revascularization Investigation
-
Szczech LA, Best PJ, Crowley E, et al. Outcomes of patients with chronic renal insufficiency in the Bypass Angioplasty Revascularization Investigation. Circulation. 2002;105:2253-2258.
-
(2002)
Circulation
, vol.105
, pp. 2253-2258
-
-
Szczech, L.A.1
Best, P.J.2
Crowley, E.3
-
48
-
-
7044222175
-
Impact of mild or moderate chronic kidney disease on the frequency of restenosis: Results from the PRESTO Trial
-
Best PJ, Berger PB, Davis BR, et al. Impact of mild or moderate chronic kidney disease on the frequency of restenosis: results from the PRESTO Trial. J Am Coll Cardiol. 2004;44:1786-1791.
-
(2004)
J Am Coll Cardiol.
, vol.44
, pp. 1786-1791
-
-
Best, P.J.1
Berger, P.B.2
Davis, B.R.3
-
49
-
-
17844370790
-
Association of chronic kidney disease with clinical outcomes after coronary revascularization: The Arterial Revascularization Therapies Study (ARTS)
-
Ix JC, Mercado N, Shlipak MG, et al. Association of chronic kidney disease with clinical outcomes after coronary revascularization: the Arterial Revascularization Therapies Study (ARTS). Am Heart J. 2005;149:512-519.
-
(2005)
Am Heart J.
, vol.149
, pp. 512-519
-
-
Ix, J.C.1
Mercado, N.2
Shlipak, M.G.3
-
50
-
-
28844443938
-
Impact of moderate renal insufficiency on restenosis and adverse clinical events after paclitaxel-eluting and bare metal stent implantation: Results from the TAXUS-IV trial
-
Halkin A, Mehran R, Casey CW, et al. Impact of moderate renal insufficiency on restenosis and adverse clinical events after paclitaxel-eluting and bare metal stent implantation: results from the TAXUS-IV trial. Am Heart J. 2005;150:1163-1170.
-
(2005)
Am Heart J.
, vol.150
, pp. 1163-1170
-
-
Halkin, A.1
Mehran, R.2
Casey, C.W.3
-
51
-
-
0022649785
-
Moderate doses of aspirin and risk of bleeding in renal failure
-
Livio M, Benigni A, Vigano G, et al. Moderate doses of aspirin and risk of bleeding in renal failure. Lancet. 1986;1:414-416.
-
(1986)
Lancet
, vol.1
, pp. 414-416
-
-
Livio, M.1
Benigni, A.2
Vigano, G.3
-
53
-
-
0141594931
-
Bivalirudin provides increasing benefit with decreasing renal function: A meta-analysis of randomized trials
-
Chew DP, Bhatt DL, Kimball W, et al. Bivalirudin provides increasing benefit with decreasing renal function: a meta-analysis of randomized trials. Am J Cardiol. 2003;92:919-922.
-
(2003)
Am J Cardiol.
, vol.92
, pp. 919-922
-
-
Chew, D.P.1
Bhatt, D.L.2
Kimball, W.3
-
54
-
-
0041488808
-
Safety of abciximab in patients with chronic renal insufficiency who are undergoing percutaneous coronary interventions
-
Best PJ, Lennon R, Gersh BJ, et al. Safety of abciximab in patients with chronic renal insufficiency who are undergoing percutaneous coronary interventions. Am Heart J. 2003;146: 345-350.
-
(2003)
Am Heart J.
, vol.146
, pp. 345-350
-
-
Best, P.J.1
Lennon, R.2
Gersh, B.J.3
-
55
-
-
0037420072
-
Influence of concurrent renal dysfunction on outcomes of patients with acute coronary syndromes and implications of the use of glycoprotein IIb /IIIa inhibitors
-
Freeman RV, Mehta RH, Al Badr W, et al. Influence of concurrent renal dysfunction on outcomes of patients with acute coronary syndromes and implications of the use of glycoprotein IIb/IIIa inhibitors. J Am Coll Cardiol. 2003;41:718-724.
-
(2003)
J Am Coll Cardiol.
, vol.41
, pp. 718-724
-
-
Freeman, R.V.1
Mehta, R.H.2
Al Badr, W.3
-
56
-
-
33846498266
-
-
ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Available at
-
ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Available at www.acc.org/clinical/guidelines/percutaneous/update/index.pdf
-
-
-
|